Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darlene Lu

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2013
Virologic response, early HIV-1 decay, and maraviroc pharmacokinetics with the nucleos(t)ide-free regimen of maraviroc plus darunavir/ritonavir in a pilot studyBabafemi Taiwo, Edward P Acosta, Patrick Ryscavage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE StudyAnne F Luetkemeyer, Susan L Rosenkranz, Darlene Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2019
Heterogeneity and Spatial Distribution of Intravertebral Trabecular Bone Mineral Density in the Lumbar Spine Is Associated With Prevalent Vertebral FractureJarred Kaiser, Brett Allaire, Paul M Fein, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
Translational Vision Science & Technology|November 14, 2024
Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History StudyJames Whelan, Jane Green, Marie Burstedt, et al.
Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.
JBMR Plus|March 1, 2022
Temporal and Quantitative Transcriptomic Differences Define Sexual Dimorphism in Murine Postnatal Bone AgingDarlene Lu, Serkalem Demissie, Nina B Horowitz, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumorsTodd M Bauer, Armando Santoro, Chia-Chi Lin, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Cancer Discovery|May 30, 2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical DevelopmentMichael J Dickinson, Pere Barba, Ulrich Jäger, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Acquired Immune Deficiency Syndromes (1999)|June 26, 2013
Virologic response, early HIV-1 decay, and maraviroc pharmacokinetics with the nucleos(t)ide-free regimen of maraviroc plus darunavir/ritonavir in a pilot studyBabafemi Taiwo, Edward P Acosta, Patrick Ryscavage, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 18, 2013
Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE StudyAnne F Luetkemeyer, Susan L Rosenkranz, Darlene Lu, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 31, 2019
Heterogeneity and Spatial Distribution of Intravertebral Trabecular Bone Mineral Density in the Lumbar Spine Is Associated With Prevalent Vertebral FractureJarred Kaiser, Brett Allaire, Paul M Fein, et al.
The Journal of Infectious Diseases|June 27, 2013
Three distinct phases of HIV-1 RNA decay in treatment-naive patients receiving raltegravir-based antiretroviral therapy: ACTG A5248Adriana Andrade, Susan L Rosenkranz, Anthony R Cillo, et al.
Translational Vision Science & Technology|November 14, 2024
Patient-Reported Outcomes in RLBP1 Retinal Dystrophy: Longitudinal Assessment in a Prospective Natural History StudyJames Whelan, Jane Green, Marie Burstedt, et al.
Plos One|December 25, 2013
Dynamics of immune reconstitution and activation markers in HIV+ treatment-naïve patients treated with raltegravir, tenofovir disoproxil fumarate and emtricitabineNicholas T Funderburg, Adriana Andrade, Ellen S Chan, et al.
JBMR Plus|March 1, 2022
Temporal and Quantitative Transcriptomic Differences Define Sexual Dimorphism in Murine Postnatal Bone AgingDarlene Lu, Serkalem Demissie, Nina B Horowitz, et al.
Journal for Immunotherapy of Cancer|November 29, 2023
Phase I/Ib, open-label, multicenter, dose-escalation study of the anti-TGF-β monoclonal antibody, NIS793, in combination with spartalizumab in adult patients with advanced tumorsTodd M Bauer, Armando Santoro, Chia-Chi Lin, et al.
The Lancet. HIV|October 2, 2015
Partner-based adherence intervention for second-line antiretroviral therapy (ACTG A5234): a multinational randomised trialRobert Gross, Lu Zheng, Alberto La Rosa, et al.
Cancer Discovery|May 30, 2023
A Novel Autologous CAR-T Therapy, YTB323, with Preserved T-cell Stemness Shows Enhanced CAR T-cell Efficacy in Preclinical and Early Clinical DevelopmentMichael J Dickinson, Pere Barba, Ulrich Jäger, et al.
Pageof 3